imatinib mesylate has been researched along with Injuries, Spinal Cord in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, J; Li, L; Song, B; Wang, L; Zhang, Y; Zhao, J | 1 |
| Sharp, KG; Steward, O; Yee, KM | 1 |
| Abrams, M; Eriksson, U; Finn, A; Hao, J; Josephson, A; Kjell, J; Olson, L; Svensson, CI; Wellfelt, K; Wiesenfeld-Hallin, Z | 1 |
| Abrams, MB; Codeluppi, S; Eriksson, U; Kjell, J; Lewandowski, SA; Nilsson, I; Olson, L | 1 |
4 other study(ies) available for imatinib mesylate and Injuries, Spinal Cord
| Article | Year |
|---|---|
The effects of Glivec on the urinary bladder excitation of rats with suprasacral or sacral spinal cord transection.
Topics: Animals; Benzamides; Calcium; Dose-Response Relationship, Drug; Female; Imatinib Mesylate; Interstitial Cells of Cajal; Models, Animal; Muscle Contraction; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Rats; Rats, Sprague-Dawley; Sacrum; Signal Transduction; Spinal Cord Injuries; Urinary Bladder | 2013 |
A re-assessment of treatment with a tyrosine kinase inhibitor (imatinib) on tissue sparing and functional recovery after spinal cord injury.
Topics: Animals; Benzamides; Disease Models, Animal; Female; Hindlimb; Imatinib Mesylate; Motor Activity; Nerve Fibers, Myelinated; Nerve Regeneration; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Sprague-Dawley; Recovery of Function; Reflex; Spinal Cord Injuries; Urinary Bladder | 2014 |
Delayed Imatinib Treatment for Acute Spinal Cord Injury: Functional Recovery and Serum Biomarkers.
Topics: Animals; Biomarkers; Cytokines; Disease Models, Animal; Female; Imatinib Mesylate; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Recovery of Function; Spinal Cord Injuries; Time Factors | 2015 |
Imatinib enhances functional outcome after spinal cord injury.
Topics: Animals; Astrocytes; Benzamides; Blood-Brain Barrier; Chondroitin Sulfate Proteoglycans; Disease Models, Animal; Female; Imatinib Mesylate; Inflammation; Mice; Mice, Transgenic; Motor Activity; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rats; Receptors, Platelet-Derived Growth Factor; Recovery of Function; Spinal Cord Injuries; Treatment Outcome | 2012 |